Search results for: 'negotiation'

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generation of evidence to support the drug’s value proposi...

In Q3 2018, regional growth in the Western Europe region remained stagnated at 1.6% with growth expected to remain low during the forecast period predominantly due to uncertainties arising out of the Brexit issues and slow growth outlook in emerging markets. Economic growth in Germany appears to have touched a near-zero situation in Q4 2018 and is ...

Static water utility infrastructures are increasingly unable to cope with future demands. Climate change, water scarcity, energy costs, population shifts, budget cuts, and stricter legislation also challenge water services. At the same time, the responsibility of governments to ensure high-quality and accessible water through water and wastewater ...

As Europe battles unequal growth and environmental, economic, social, and political challenges, Britain has chosen to fight its challenges alone. This study puts forth a hypothetical timeline to the events that might unfold in the next five years and examines the potential trade models that may come to reality between Britain and the European Union...

07 Oct 2025  |  Global  |  Market Research

Industrial Hybrid AI Market, Global, 2024–2029

Industrial Hybrid AI Market is Experiencing Transformational Growth due to the Urgency for Adaptive Intelligence in Critical Decision-Making

Infographics

×

Hybrid AI is an integrative approach reshaping how AI is applied to mission-critical applications. Its potential lies in addressing the critical limitations of current AI solutions, with key market drivers including enhanced interpretability and explainability, greater application flexibility, and improved scalability and efficiency. Strong growth ...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

This research service offers comprehensive discussions about the key approvals, mergers and acquisitions, product licensing deals, and digital partnerships of the pharmaceutical industry in 2022. A renewed focus on operational excellence and digital transformation will push top-line pharmaceutical industry growth and drive strong partnerships with ...

Enhanced mining production levels and a recovery in CAPEX for plant, machinery, and equipment drive the demand for mining lubricants and greases in the Australian market. Mining CAPEX peaked in 2012 and rapidly declined, and steady improvement as seen in the recent past is likely to continue. However, price sensitivity among customers will restrain...

The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond. It addresses the impact of innovative modalities, technologies, ...